Preparing for Your First FDA Inspection: A Step-by-Step Guide

Understanding FDA's Inspection Approach

FDA inspections of compounding pharmacies are not random audits — they follow a structured methodology designed to evaluate your facility's compliance across interconnected systems. Understanding this methodology is the first step toward effective preparation. An FDA inspection can be triggered by routine scheduling, a complaint, an adverse event report, or the agency's risk-based prioritization (such as the enhanced surveillance period following the peptide reclassification).

Regardless of the trigger, inspectors use a systems-based approach that evaluates your operation holistically rather than checking individual items in isolation.

The 6-System Inspection Framework

FDA organizes its inspection findings around six interconnected systems. Inspectors typically begin with one or two systems and expand their scope based on what they find.

1. Quality System

This is the umbrella system that governs all others. Inspectors evaluate your overall quality management structure: CAPA processes, deviation handling, change control, management review, internal audits, and complaint handling. A weak quality system suggests that problems in other systems are not being detected or corrected.

2. Facilities and Equipment System

Covers your physical infrastructure: cleanroom design and classification, HVAC systems, differential pressure monitoring, equipment qualification and maintenance, calibration programs, and cleaning validation. Inspectors will walk your facility, check gauges, review maintenance logs, and verify that your environmental controls match your documentation.

3. Materials System

Evaluates how you manage incoming materials: supplier qualification, receiving procedures, identity testing, Certificate of Analysis review, storage conditions, inventory control, and material rejection/disposition processes. Inspectors may trace a specific ingredient from receipt through use in a batch record.

4. Production System

Examines your compounding operations: batch records, formula management, in-process controls, process validation (for 503B), equipment cleaning between products, and yield reconciliation. Inspectors will select batch records and trace every step from formula to finished product.

5. Packaging and Labeling System

Reviews how finished preparations are packaged, labeled, and stored before dispensing. This includes label accuracy, beyond-use dating, storage conditions, and controls to prevent mix-ups.

6. Laboratory Control System

Covers all testing activities: environmental monitoring, sterility testing, endotoxin testing, potency testing (for 503B), stability programs, and laboratory equipment calibration. Inspectors will review raw data, not just final results.

Pre-Inspection Checklist

While you should always be inspection-ready, there are specific preparations to make when you know an inspection is imminent or likely.

• Document organization: Ensure all SOPs are current (no expired versions in use), all training records are complete and accessible, and all equipment calibration and maintenance records are up to date. An inspector should be able to request any document and have it produced within minutes, not hours.
• Self-inspection: Conduct a thorough mock inspection using a standardized checklist that covers all six FDA systems. Document findings and address any gaps before the real inspection. A 40-item mock inspection checklist covering the most common 483 observations is a good starting point.
• CAPA review: Ensure all open CAPAs are progressing on schedule. Close any CAPAs that have completed effectiveness verification. Overdue CAPAs are a red flag that inspectors specifically look for.
• Environmental data review: Review recent environmental monitoring data for any trends, excursions, or gaps. Ensure all excursion investigations are documented and closed. Verify that your SPC charts show processes in control.
• Training status: Verify that all personnel have current competency assessments and that no assessments are overdue. Ensure new employees hired in the past 6 months have completed all required initial training.
• Batch record review: Randomly sample recent batch records and verify completeness — every field filled, every signature present, every deviation noted and investigated.

Day-of Preparation

When inspectors arrive, your response sets the tone for the entire inspection.

• Designated escort: Assign a knowledgeable person (typically the quality manager or pharmacy director) to accompany inspectors at all times. This person should be able to answer questions or quickly locate someone who can.
• Document staging area: Set up a dedicated space where inspectors can review documents. Have your organizational chart, facility map, SOP index, and key compliance summaries readily available.
• Staff preparation: Brief all staff on inspection protocols — answer questions honestly, do not volunteer information beyond what is asked, and immediately notify the escort if an inspector requests something unusual.
• Parallel documentation: Have someone take detailed notes on every inspector request, every document provided, and every observation made. This record is invaluable for responding to any findings.

Common 483 Observations

Certain inspection findings appear repeatedly across compounding pharmacy inspections. Knowing these patterns helps you prioritize your preparation:

• Inadequate environmental monitoring: Gaps in continuous monitoring, missing excursion documentation, no trending analysis.
• Incomplete batch records: Missing signatures, undocumented deviations, calculation errors without correction documentation.
• Training deficiencies: Overdue competency assessments, missing media fill documentation, no evidence of remediation after failed assessments.
• SOP non-compliance: Expired SOPs still in use, staff unable to locate current versions, procedures that do not match actual practice.
• Calibration lapses: Overdue calibrations, missing NIST traceability, no out-of-calibration impact assessments.
• Data integrity issues: Incomplete audit trails, shared login credentials, backdated records.

Building an Always-Ready Culture

The pharmacies that handle inspections best are those that do not treat inspection preparation as a special event. Instead, they build compliance into daily operations so that every day is inspection-ready. This means automated environmental monitoring that runs continuously, not just when someone remembers to check. Training systems that automatically schedule and track competency assessments. CAPA workflows that enforce timelines and escalate overdue items. Document management that ensures only current versions are accessible.

CompliRx was built to make always-on compliance practical. With real-time environmental monitoring, automated task generation, compliance scoring across all eight quality categories, an inspector view mode that shows your facility through FDA's lens, and mock inspection checklists that auto-assess from live data, CompliRx transforms inspection readiness from a scramble into a daily reality. Start your 90-day pilot and see the difference a purpose-built compliance platform makes.